-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Silexion Therapeutics Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2023 to 2024.
- Silexion Therapeutics Corp Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $3K, a 50% increase year-over-year.
- Silexion Therapeutics Corp annual Income Tax Expense (Benefit) for 2024 was $10K, a 68.8% decline from 2023.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)